Publications dans lesquelles il/elle collabore avec María Lourdes Vázquez López (21)
2024
-
Treatment of post-allogeneic hematopoietic stem cell transplant cytopenias with sequential doses of multipotent mesenchymal stromal/stem cells
Cytotherapy, Vol. 26, Núm. 8, pp. 806-812
2022
-
CT-169 Cytokine Release Syndrome After Peripheral Blood Haploidentical Stem Cell Transplantation With Post-Transplant Cyclophosphamide: Time of Onset Matters
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S437-S438
-
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients
Leukemia and Lymphoma, Vol. 63, Núm. 3, pp. 538-550
2019
-
Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation
Bone Marrow Transplantation
2016
2015
-
Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant
British Journal of Haematology, Vol. 169, Núm. 5, pp. 719-725
-
Influence of donor age in allogeneic stem cell transplant outcome in acute myeloid leukemia and myelodisplastic syndrome
Leukemia Research, Vol. 39, Núm. 8, pp. 828-834
2014
-
Late differentiation syndrome in acute promyelocytic leukemia: A challenging diagnosis
Hematology Reports, Vol. 6, Núm. 4, pp. 75-77
-
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus
Bone Marrow Transplantation, Vol. 49, Núm. 5, pp. 684-690
2013
-
Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients
Haematologica, Vol. 98, Núm. 3, pp. 437-443
2011
-
Effect of vitamin D treatment in chronic GVHD
Bone Marrow Transplantation
-
Ischemic stroke associated with the infusion of DMSO-cryopreserved auto-PBSCs
Bone Marrow Transplantation
2010
-
Liver function tests and absolute lymphocyte count at day +100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant
American Journal of Hematology, Vol. 85, Núm. 4, pp. 290-293
2009
-
Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Chronic Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation, Vol. 15, Núm. 10, pp. 1331-1336
2008
-
Prognostic Factors of Chronic Graft-versus-Host Disease Following Allogeneic Peripheral Blood Stem Cell Transplantation: The National Institutes Health Scale Plus the Type of Onset Can Predict Survival Rates and the Duration of Immunosuppressive Therapy
Biology of Blood and Marrow Transplantation, Vol. 14, Núm. 10, pp. 1163-1171
2006
-
Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Acute Graft-versus-Host Disease (GVHD)
Biology of Blood and Marrow Transplantation, Vol. 12, Núm. 9, pp. 936-941
2005
-
CD34+ cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation
Leukemia and Lymphoma, Vol. 46, Núm. 2, pp. 177-183
-
Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: A comparison with their respective sibling donors
Biology of Blood and Marrow Transplantation, Vol. 11, Núm. 5, pp. 354-361
-
Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability
Experimental Hematology, Vol. 33, Núm. 8, pp. 935-943
2003
-
Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation
Blood, Vol. 102, Núm. 3, pp. 1108-1113